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Abstract
Background: The activation and effector phenotype of T cells depend on the strength of the
interaction of the TcR with its cognate antigen and additional signals provided by cytokines and by
co-receptors. Lymphocytes sense both the presence of an antigen and also clues from antigen-
presenting cells, which dictate the requisite response. CD43 is one of the most abundant molecules
on the surface of T cells; it mediates its own signalling events and cooperates with those mediated
by the T cell receptor in T cell priming. We have examined the role of CD43 signals on the effector
phenotype of adult CD4+ and CD8+ human T cells, both alone and in the presence of signals from
the TcR.
Results: CD43 signals direct the expression of IFNγ in human T cells. In freshly isolated CD4+ T
cells, CD43 signals potentiated expression of the IFNγ gene induced by TcR activation; this was not
seen in CD8+ T cells. In effector cells, CD43 signals alone induced the expression of the IFNγ gene
in CD4+ T cells and to a lesser extent in CD8+ cells. The combined signals from CD43 and the TcR
increased the transcription of the T-bet gene in CD4+ T cells and inhibited the transcription of the
GATA-3 gene in both populations of T cells, thus predisposing CD4+ T cells to commitment to the
T1 lineage. In support of this, CD43 signals induced a transient membrane expression of the high-
affinity chains of the receptors for IL-12 and IFNγ in CD4+ T cells. CD43 and TcR signals also
cooperated with those of IL-12 in the induction of IFNγ expression. Moreover, CD43 signals
induced the co-clustering of IFNγR and the TcR and cooperated with TcR and IL-12 signals,
triggering a co-capping of both receptors in CD4+ populations, a phenomenon that has been
associated with a T1 commitment.
Conclusion: Our results suggest a key role for CD43 signals in the differentiation of human CD4+
T cells into a T1 pattern.
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Background
When T cells encounter antigen-presenting cells (APC)
loaded with a peptide that they specifically recognize, they
mature to become effector cells [1]. There are three major
sub-populations of effector cells. Type One (T1) cells
secrete IFNγ, IL-2 and TNFβ and mediate a systemic cellu-
lar immune response, through the activation of macro-
phages and cytotoxic T cells [2,3]. Type Two (T2) cells
secrete IL-4, IL-5 and IL-13, and potentiate the isotype
switching of immunoglobulins to IgG1 and IgE, promot-
ing neutralizing activity and degranulation of mast cells,
thereby inducing a barrier immunity [4]. The Type 17
(T17) cells, recently described, produce IL-17A and F, G-
CSF and the chemokines CXCL9, CXCL10 and CXCL11. It
promotes life and differentiation of neutrophils and is
important in the clearance of extracellular bacteria [5].
Naïve cells can also differentiate into regulatory cells,
either TH3 (TGFβ producers), TR1 (IL-10 producers) or
iTREG (IL-10 and TGFβ producers) [6]. Differentiation of
cells into T1 or T2 effector cells has been shown mostly to
occur in CD4+ and CD8+ T cells, although other immune
cells also differentiate into these two patterns [1].
The clone-specific T cell response is provided by signals
from the T cell receptor (TcR). Yet additional signals, pro-
vided by cytokines and by co-receptors, are also required
for the activation and for the determination of the
cytokine profile of T cells. Thus, a lymphocyte senses not
only the presence of an antigen but also its environment
and a particular cellular response will result from the inte-
gration of signals delivered by the antigen – specific recep-
tor and the numerous co-receptors and cytokine receptors
[7].
The initial signals of differentiation can occur in the
absence of cytokines [8]. The stabilization of the differen-
tiated phenotype, however, is thought to depend mostly
on cytokines [9]. The cytokines IL-12 and IL-4 play a direct
role in the differentiation of lymphocytes into the T1 or
T2 patterns, respectively. When activated T cells are cul-
tured in the presence of IL-12 and blocking antibodies
against IL-4, they differentiate into the T1 pattern. In the
same way, activated cells cultured in the presence of IL-4
and blocking antibodies against IFNγ differentiate into T2
cells [4]. An extensive amount of work has documented
the direct involvement of cytokines in the in vivo differen-
tiation of T cells into the T1 or T2 patterns [10].
CD43 is a very large and heavily glycosylated molecule,
very abundant on the T cell surface [11]. It was originally
proposed that its main function was to repulse the inter-
actions between the APC and the T cell, because of its
strong negative charge due to the abundance of sialic acid,
and extended nature [12]. In addition, during the rear-
rangement of molecules that accompanies antigen – spe-
cific T cell activation, CD43 is excluded from the T-cell –
APC contact region, which contains the TcR, as well as
other co-receptor molecules [13]. CD43 exclusion from
the immunological synapses is an active phenomenon,
which gives rise to the formation of a distal complex,
probably with signalling activity [14,15]. Even so, the
presence of the extracellular domain of CD43 in the con-
tact area between the APC and the T cell does not affect the
T cell response [16]. Furthermore, CD43 mediates its own
signalling events and cooperates with those mediated by
the TcR in T cell priming, as determined in total popula-
tions of T cells [17-20].
We evaluated the role of CD43 signals, alone or combined
with TcR or IL-12 signals on: a) the expression of IFNγ and
IL-4, b) the transcription of T-bet and GATA-3 genes, c)
the membrane expression of IL-12R and IFNγR and d) the
distribution of IFNγR and the TcR on the surface of
human T cells. Our results show that CD43 signals pro-
mote T cell commitment to the T1 differentiation pattern
in adult T cells, particularly the CD4+ subset.
Results
CD43 signals induce IFNγ gene expression
We evaluated the role of CD43 signals in the commitment
of human CD4+ and CD8+ T cells into IFNγ producers. In
freshly isolated cells, CD43 – ligation induced a modest
change in the percentage of IFNγ+ cells in CD4+ but not in
CD8+ T cells. Engagement of the TcR led to a substantial
increase in the percentage of IFNγ+ cells both in the CD4+
and CD8+ T cell populations. The simultaneous ligation of
CD43 and the TcR strongly increased the proportion of
IFNγ+ CD4+ T cells, but not that of CD8+ T cells (Figure 1A
and 1B, left panel). The CD43 plus TcR induced increase
in IFNγ+ CD4+ T cells is accompanied by a simultaneous
decrease in IL-4+ cells (Figure 1A).
Next, we evaluated the effect of CD43 signals on cells dif-
ferentiated for one week under T1 or T2 polarizing condi-
tions (Figure 1B) [21]. In T1 cells, CD43 or the TcR
independently were sufficient to induce the expression of
IFNγ in CD4+  T cells (68% and 64% over 12.8% in
untreated cells), and to a lower extent in CD8+  cells
(26.3% and 18.5% over 14% in untreated cells). In the T2
effector cells, CD43, but not the TcR, induced the expres-
sion of IFNγ, in both CD4+ and CD8+ cells (43.4% and
38.1% over 5% and 6% in the untreated cells). These
results indicate that in CD4+ human T cells, CD43 signals
induce a T1 cytokine pattern. In freshly isolated cells,
CD43 signals require in addition signals from the TcR but
not in either T1 or T2 differentiated cells. Furthermore, in
T2 differentiated CD8+ T cells, CD43, but not the TcR, sig-
nals induced the expression of IFNγ. A significant increase
in IFNγ expression was also observed in response to the
joint signals of CD43 and the TcR in freshly isolated cellsBMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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depleted of CD45RO+ (memory) cells and in human neo-
natal T cells (data not shown and manuscript in prepara-
tion).
In freshly isolated CD4+ T cells, the increase in the per-
centage of IFNγ+ cells in response to CD43 signals corre-
lated with a decrease of IL-4+ cells (Figure 1A). We thus
investigated the effect of CD43 signals in the transcription
of the IFNγ and IL-4 genes (Figure 2). In CD4+ T cells, the
joint signals of CD43 and the TcR strongly induced IFNγ
gene transcription (panel A). Neither CD43 nor the TcR
signals alone were sufficient to induce IFNγ gene tran-
scription. Alone or in combination, CD43 and the TcR
were inhibitory of basal IL-4 transcription (panel B). In
CD8+ cells, CD43 signals did not affect the transcription
of either the IFNγ or IL-4 genes (panels C and D) yet those
of the TcR induced IFNγ transcription with no change in
IL-4 mRNA levels. The joint signals from CD43 and the
TcR stimulated IL-4 transcription over the levels found in
response to TcR signals, consistent with the fact that in
CD8+ cells, the combination of CD43- and TCR-depend-
ent signals did not result in a higher proportion of INFγ+
CD43 and TcR signals induce the expression of IFNγ in CD4+ T cells Figure 1
CD43 and TcR signals induce the expression of IFNγ in CD4+ T cells. CD4+ or CD8+ T cells were used freshly isolated 
or after differentiation for one week under T1 or T2 polarizing conditions. Panel A shows the simultaneous analysis of IL-4 and 
IFNγ expression in freshly isolated cells. In Panel B we show the comparison of IFNγ expression in freshly isolated cells (left 
panel), and in T1 and T2 differentiated populations. Cells were left non-stimulated or were stimulated for 12 h by antibody liga-
tion of CD3 (TcR), CD43 or the simultaneous ligation of both molecules. Cells were collected and stained with FITC-labelled 
anti-IFNγ antibody and analyzed by flow cytometry. Representative experiments, out of at least three are shown, using CD4+ 
or CD8+ T cells from the same donor.BMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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cells (Figure 1). CD43 expression was similar in all the
populations of cells, as evaluated by L10 staining (data
not shown).
Effect of CD43 signals in the transcription of the T-bet and 
GATA-3 genes
Differentiation into effector T cells is accompanied by the
selective expression of lineage-specific transcription fac-
tors. T-bet and GATA-3 have been described as the signa-
ture transcription factors for differentiation of T1 and T2
cells, respectively [22,23]. Although CD43 signals alone
had no effect on the transcription of T-bet or GATA-3
genes, in cooperation with those of the TcR, led to a
marked inhibition of the GATA-3 gene transcription in
both, CD4+ or CD8+ T cells (Figure 3A and 3B). Moreover,
in CD4+ T cells, the combined signals of CD43 and the
TcR induced the transcription of the T-bet gene (Figure
3B). The CD43-mediated increase in T-bet and inhibition
of GATA-3 genes transcription, could direct CD4+ T cell
differentiation into the T1 pattern.
CD43 ligation increased the expression of IL-12 and IFNγ 
receptor
Cytokine expression depends on signals from co-receptors
as well as from cytokines. Upon interaction with their
receptors, IL-12 and IFNγ induce T1- and IL-4 T2-differen-
tiation patterns [2,9]. We investigated the effects of signals
from the TcR, CD43 and IL-12 in the membrane-expres-
sion levels of IL-12 (IL-12R) and IFNγ (IFNγR) receptors
in CD4+ T cells. IL-12R and IFNγR are expressed at low lev-
els in non-stimulated CD4+ T cells [24,25]. CD43-ligation,
but not that of the TCR, induced an increase in the per-
CD43 and TcR signals induce the transcription of IFNγ in CD4+ and IL-4 in CD8+ T cells Figure 2
CD43 and TcR signals induce the transcription of IFNγ in CD4+ and IL-4 in CD8+ T cells. T cells were treated for 6 
h as indicated in Figure 1. Total RNA was extracted from CD4+ (panel A and C) or CD8+ T cells (panel B and D) and subjected 
to real time RT-PCR analysis for IFNγ (panels A and B) or IL 4 (panels C and D) mRNA contents. A representative of at least 
3 independent experiments is shown. Each point is the mean of duplicates which differed by <2%.BMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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centage of IL-12R+ or IFNγR+ cells. As expected, the IL-12
signals augmented the percentage of IL-12R+ and IFNγR+
cells (Figure 4).
IL-12 signals augment the induction of IFNγ in response to 
CD43 and TcR signals in CD4+ T cells
We next investigated if CD43 signals affected the IL-12-
driven transcription of IFNγ in CD4+ T cells. The individ-
ual signals from CD43 or the TcR did not alter the IL-12-
induced IFNγ transcription. The combination of CD43,
the TcR and IL-12 signals led, however, to a 20% increase
of the IFNγ gene transcription over that resulting of the
joint signals of CD43 and the TcR (Figure 4B). This
enhancement was also reflected at the protein level,
because the percentage of IFNγ+ cells increased when IL-12
was added together with anti-TCR and anti-CD43 mAbs
(data not shown). As expected, IL-12 signals induced IFNγ
transcription. These results suggest that CD43-mediated
signals favour the IL-12-driven differentiation into T1
cells.
CD43 signals induce the co-clustering of IFNγR and the 
TcR
The membrane distribution of IFNγR and the TcR has
been shown to determine the effector phenotype of lym-
phocytes. When IL-12 is present during activation, the co-
capping of the TcR and IFNγR gives rise to a T1 differenti-
ation pattern [26]. We found that in CD4+ T cells, the TcR
and IFNγR always co-localized, whether the cells were
stimulated or not (Figure 5). The separate signals of
CD43, the TCR and IL-12 all induced a significant increase
in the percentage of cells with TcR and IFNγR co-clustering
(Table 1). The joint signals of CD43 and the TcR increased
this percentage over that resulting of the individual stim-
uli. Addition of IL-12 simultaneous with CD43 and TCR
ligation did not augment the proportion of cells with co-
clustered receptors over that found for CD43- or CD43-
and TcR-treated cells. The addition of IL-12 to TcR-ligated
cells, however, augmented the proportion of cells with co-
clustered receptors as related to TcR-ligated cells (Table 1).
The localization and topography of the TcR and IFNγR
clusters also changed in response to the different stimuli.
In IL-12-treated cells, both receptors redistributed towards
one half of the cell in a few big clusters (Figure 5, lane 2).
CD43 signalling resulted in smaller clusters all over the
cells or towards one pole (lane 3), whereas the joint sig-
nals from CD43 and IL-12 (lane 4) or of CD43 and the
TcR (lane 7) promoted the formation of a co-cap of the
TcR and IFNγR in one extreme of the cells. No further
effect was observed as a result of the combined signals of
CD43, the TcR and IL-12 (lane 8). Signals from the TcR
alone induced the redistribution of the TCR and IFNγR
towards one half of the cell, and the addition of IL-12 did
not change the phenotype (lanes 5 and 6). In CD8+ T cells,
the TcR and IFNγR did not co-localize and CD43 signals
CD43 and TcR signals induce the transcription of the T-bet gene in CD4+ T cells and inhibit GATA-3 gene transcription in both  CD4+ and CD8+ T cells Figure 3
CD43 and TcR signals induce the transcription of the T-bet gene in CD4+ T cells and inhibit GATA-3 gene tran-
scription in both CD4+ and CD8+ T cells. T cells were treated for 6 h, as indicated in Figure 1. Total RNA was extracted 
from CD4+ (panel A) or CD8+ T cells (panel B) and subjected to real time RT-PCR analysis for T-bet or GATA-3 mRNAs as 
compared to the internal control GAPDH. The graphics show the fold change in the levels of the messengers, as compared to 
untreated cells (base line). A representative of four independent experiments is shown. Each point is the mean of duplicates 
which differed by <2%.BMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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did not affect the aggregation of either receptor (Figure 5
insert)
Finally, we examined whether IL-4 signals disrupted the
TcR and IFNγR co-clustering. In murine cells, It has been
shown that IL-4 signals inhibit the co-clustering of the TcR
and IFNγR and that, as a consequence, cells differentiate
into T2 [26]. In agreement with this, IL-4 signals inhibited
the redistribution of receptors resulting from IL-12, CD43
or TcR engagement alone or in different combinations
(Table 1).
Discussion
We evaluated the effect of CD43 signals alone or in com-
bination with those of the TcR on IFNγ expression in
freshly isolated CD4+ or CD8+ T cells and in T1 or T2 effec-
tor cells. In freshly isolated CD4+ T cells, CD43 signals
alone led to a small increase in the percentage of IFNγ+
cells, and synergized with TCR signals in the induction of
IFNγ+ cells. This was not observed in CD8+ T cells stimu-
lated under the same experimental conditions. On effec-
tor cells, CD43 signals alone lead to a strong induction of
IFNγ not only in T1 but also in T2 CD4+ cells and to a
CD43 induces IFNγR and IL-12R expression and cooperates with IL-12 for IFNγ transcription in CD4+ T cells Figure 4
CD43 induces IFNγR and IL-12R expression and cooperates with IL-12 for IFNγ transcription in CD4+ T cells. 
CD4+ T cells were left non-stimulated (none), or were stimulated for 24 h (A), by antibody ligation of CD3 (TcR) or CD43 fol-
lowed by cross-linking with a secondary antibody or were stimulated for 12 h (B) by antibody ligation of CD3 (TcR), CD43, or 
the simultaneous ligation of both molecules, in the presence or absence of IL-12. A) Cells were collected and stained with 
FITC-labelled anti-IL-12R and PE-labelled anti-IFNγR antibodies and analyzed by flow cytometry. The graphics show the fold 
change in the expression levels of the receptors, as compared to untreated cells. The corresponding histograms are shown to 
the left of the graph. B) Total RNA was extracted and subjected to real time RT-PCR analysis for IFNγ mRNA contents, as 
compared to the internal control GAPDH. A representative of two (A) or three (B) experiments is shown.BMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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lower extent in CD8+ cells. These data suggest a specific
role of CD43 signals in IFNγ expression.
The biology, function and distribution of CD4+ and CD8+
T cells during an immune response are different. We
found that CD8+ T cells are less responsive to CD43-
dependent signals. A differential response of CD4+ and
CD8+ T cells to co-receptors has also been observed for the
TNF family co-receptors, 4-1BB and OX40. 4-1BB prefer-
entially activates CD8+ cells, and inhibits of CD4+ T cells.
Conversely, OX40 is mainly stimulatory for CD4+ T cells
[27,28]. The differences encountered between CD4+ and
CD8+ T cells to CD43 signals are more significant in the
primary activation signals. This is consistent with data
reporting that CD8+ cells are less dependent on co-recep-
tors for activation [29].
Lineage-commitment is characterized by the cytokine pro-
files that cells populations secrete and also by the presence
of lineage-specific transcription factors that mediate epi-
genetic changes, favouring the expression of those
cytokines [30]. In addition to the IL-12- and the IFNγ-
induced transcription factors STAT-4 and STAT-1, T1 cells
express T-bet, which is considered to be the T1 signature
transcription factor [22]. In contrast, IL-4-induced STAT-6
as well as GATA-3 are characteristic of T2 cells. [23]. Here
we report that the joint signals of CD43 and the TcR
inhibited GATA-3 transcription, both in CD4+ and CD8+ T
cells, and that those signals increased the transcription of
T-bet in the CD4+ population only. To be able to respond
to T1 stimulatory cytokines, T cells up-regulate the expres-
sion of the high affinity chains of the IL-12R and IFNγR.
With specific antibodies for the α chain of IFNγR or the β1
CD43, the TcR and/or IL-12 signals induce the redistribution of the TcR and IFNγR Figure 5
CD43, the TcR and/or IL-12 signals induce the redistribution of the TcR and IFNγR. CD4+ T cells were treated for 
12 h as shown and stained with FITC-labelled anti-CD3 and PE-labelled anti-IFNγR before analysis by fluorescence microscopy. 
Insert shows a non-stimulated CD8+ T cell.BMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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chains of IL-12R, we evidenced that CD43 signals induce
the membrane expression of both receptors, thereby con-
tributing to the sensitivity of the cells towards T1-differen-
tiating cytokines.
The distribution of the TcR relative to that of IFNγR has
also been shown to be determinant for T cell commit-
ment, suggesting a crosstalk between the TcR and IFNγ sig-
nalosomes [26]. We observed that in CD4+ T cells, CD43
signals either alone or in combination with TcR and/or IL-
12R ligation led to the co-clustering of IFNγR with the
TcR, further adding to the T1-differentiating effects of
CD43. In contrast, in CD8+ cells, CD43 signals did not
affect the membrane distribution of IFNγR and the TcR in
the membrane. Moreover, we did not find that these
receptors co-localized in CD8+ T cells, where it has been
reported that the redistribution of molecules during the
immunological synapses is strongly dependent on CD8
engagement [31].
Conclusion
All together our results suggest that CD43 signals favour
CD4+ T cell differentiation to a T1 pattern. In conjunction
with TCR-dependent signals, CD43 induced T bet and
IFNγ genes and inhibited those of GATA-3 and IL-4. Con-
comitantly, CD43-treated cells became more sensitive to
the T1-inducing cytokines IFNγ and IL-12 through the up-
regulation of their receptors. Part of this could be achieved
by the CD43-mediated co-clustering of the TcR and
IFNγR.
In CD8+ T1 or T2 effector cells, CD43 signals moderately
induced IFNγ expression. In freshly isolated CD8 cells,
however, CD43 signals induced IL-4 transcription, and
failed to induce IFNγ expression. In CD4+ cells, the TcR
and IFNγR co-localize and cluster together in response to
CD43, the TCR or IL-12, whereas in the CD8+ T cells, these
receptors did not co-localize and did not re-distribute in
response to the same stimuli. Resolution of whether the
differential responses of the CD4+ and CD8+ populations
to CD43-specific signals could have a therapeutic use to
dissociate T cell-mediated cytotoxicity of the inflamma-
tory response requires further experiments.
Methods
Reagents
For ligation of CD43, we used the monoclonal antibody
L10 from Caltag laboratories (Burlingame, CA). Anti-CD3
mAb (clone SPV-T3b) and rabbit anti-mouse IgG were
from Zymed (San Francisco, CA). Antibodies for flow
cytometry and immunocytochemistry were from BD
PharMingen (San Diego, CA); using clone 4S. B3 for stain-
ing IFNγ, clone 2.4E6 for staining the β1 chain of IL-12R
and clone GIR-208 for the α chain of IFNγR. Ficoll-
Hypaque was from Sigma. dNTPs were from Roche
Molecular Biochemicals (Indianapolis, IN). Murine mam-
mary tumour virus reverse transcriptase, RNase inhibitor
and cytokines were from Invitrogen (Carlsbad. CA). All
reagents for real-time PCR were from Applied Biosystems
(Foster City, CA).
Cell preparations
Leukocyte concentrates from healthy adult donors were
provided by the Blood Bank from Hospital de Zona of the
Instituto Mexicano del Seguro Social in Cuernavaca. CD4+
or CD8+ T cells were isolated by RossetteSep separation,
following the manufacturer s instructions (StemCell Tech-
nologies, Vancouver). Cells were cultured as previously
described [19]. The purity of cell populations, assessed by
flow cytometry, was over 95% in all cell preparations. The
remaining cells being 0.5–3% the opposite T cell subset
and less than 1% CD19+ cells. Before experiments, T cells
were arrested for 12 h in RPMI supplemented with 2%
foetal calf serum. Subsequent manipulations were done in
this medium. T1 or T2 cells were differentiated for one
week as described [21]. For cell activation, T cells (5 × 106
cells/ml) were incubated in 24-well plates with the fol-
lowing antibodies, alone or in combination: L10, 1 µg/
ml; anti-CD3, 1 µg/ml, cross-linked with rabbit anti-
mouse IgG (1 µg/ml). Addition of the secondary antibody
Table 1: Co-clustering of TcR and IFNγR in response to CD43, 
the TcR and/or IL-12 or IL-4 signals
TREATMENT % OF CELLS WITH CO-CLUSTERED 
RECEPTORS (Mean ± SD)
NONE 30.6 ± 4.7
CD43 59.3 ± 4.5
IL-12 53.6 ± 4.5
CD43/IL-12 54.3 ± 1.5
IL-4 38.3 ± 5.5
CD43/IL-4 39.3 ± 3.6
TCR 54.3 ± 2.3
TCR/IL-12 60.6 ± 2.0
TCR/IL-4 29.3 ± 3.6
CD43/TCR 67.3 ± 1.5
CD43/TCR/IL-12 64.6 ± 4.2
CD43/TCR/IL-4 28.7 ± 3.0
CD4+ T cells were left non-stimulated or were stimulated for 12 h by 
antibody ligation of the TcR, CD43, or the simultaneous ligation of 
both molecules, in the presence or absence of IL-12 or IL-4. Cells 
were stained with FITC-labelled anti-CD3 and PE-labelled anti-IFNγR 
antibodies and analyzed with a fluorescent microscope. For each 
treatment we counted 100 cells and determined the percentage of 
cells with co-clustered receptors over those with an even distribution 
of receptors. Statistical significance was evaluated by the Student T 
test. Differences were significant with p < 0.01 for CD43, the TcR or 
IL-12 signals as compared with non-stimulated cells and p < 0.05 for 
the joint signals of CD43 and the TcR as compared with anti-CD3 or 
anti-CD43. The addition of IL-12 to the antibody treated cells 
resulted in a significant difference only for the anti-TCR treatment (p 
< 0.05). IL-4 significantly inhibited the co-clustering of the IFNγR and 
the TcR in all the antibodies treatments (p < 0.01).BMC Immunology 2007, 8:30 http://www.biomedcentral.com/1471-2172/8/30
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alone or in the presence of irrelevant antibodies did not
elicit cell responses (data not shown). In some experi-
ments, cells were incubated in the presence of IL-12 (10
ng/ml) or IL-4 (10 ng/ml).
Real-time PCR
Total RNA was obtained using TRizol (Invitrogen, Inc.),
following the manufacturer s instructions. cDNA was syn-
thesized from 1 µg of total RNA by standard reverse tran-
scription conditions, using primer (dT), in a final volume
of 30 µl. cDNA was diluted 1/10 and 2 µl of the diluted
sample were used for amplification in a 5700 Gene Amp
equipment (Applied Biosystems) with 15 min denatura-
tion and 1 min annealing/extension cycles. For cytokine
gene amplification we used the PDAR designed reagents
for Taqman amplification from Applied Biotechnology,
with the PDAR probe for GAPDH as comparison. The
amplification of T-bet, GATA-3, and GAPDH, used again
as control gene, was done with SYBR green labelling,
using the following oligonucleotides: GATA-3: 5' CCC
AAG AAC AGC TCG TTT AAC C, 3' AGA TGT GGC TCA
GGG AGG ACA T; T-bet: 5' CCA CCT GTT GTG GTC CAA
GTT, 3' TCC CTG CTT GGT GAT GAT CAT; GAPDH: 5'
ACC TGA CCT GCC GTC TAG AAA, 3' CCTGCT TCA CCA
CCT TCT TGA T. These oligonucleotides were designed
with primer express software (Applied Biosystems). All
the primers have equivalent melting temperatures and
give amplicons of 100–120 base pairs.
Staining for Flow Cytometry
T cells were stained for flow cytometry (FACS) analysis as
described [19]. Cells were analyzed with a FACScallibur
with the CELLQUEST program (Becton and Dickinson,
San José, CA). For cytokine staining, cells were treated
with or without the different stimuli for 12 h in the pres-
ence of brefeldin, as indicated by the manufacturer (BD).
Intracellular cytokine staining was performed with kits
from BD.
Immunocytochemistry
Cells were incubated in 24-well culture dishes, on 10%
poly-L-lysine pre-treated cover-slips, in the presence or
absence of any of the following stimuli alone and in dif-
ferent combinations: anti-CD43 mAb, anti-CD3 mAb, IL-
12 or IL-4. After 12 h incubation, the cover-slips were col-
lected and the adhering cells were fixed with 100% meth-
anol and blocked with 5% serum albumin in PBS. Cells
were then stained with anti-IFNγR labelled with phyco-
erythrin and anti-CD3 labelled with FITC. Controls were
isotype matching irrelevant antibodies labelled with the
same dyes. Cover-slips were soaked in 10% glycine in PBS
and attached to microscope slides for microscopic evalua-
tions with a Zeiss Optical slicing fluorescent microscope
Axiovert 200 M (Carl Zeiss, Oberkochen). We used an
amplification of 63× and performed 40 optical cuts of 0.2
µm. The cells were exposed to illumination for 6–8 s.
Images were captured with an Axiocam MR camera and
analyzed with the Axiovision Rel 4.4 software. The inte-
gration of the cuts is shown.
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